Important information regarding the contacts and business relationships that you make through the B2B MARKET PLACE, keep in mind that:

  1. PROCOLOMBIA accompanies companies with the purpose of facilitating business opportunities between exporters and buyers, without intervening in purchase and/or sale decisions, therefore, the contractual and legal responsibility of commercial negotiations falls directly on the companies that carried out the commercial transaction (exporter and buyer).
  2. Although PROCOLOMBIA carries out a preliminary investigation of the companies as part of its work methodology and commercial management, this process does not constitute any guarantee of compliance in the negotiations between the parties, for this reason it is recommended that both the exporter and the buyer carry out their own validations and protect their commercial operations with the mechanisms available in international trade regulations.
  3. The relationship between PROCOLOMBIA and the companies in Colombia and abroad, is generated through trust and the experience acquired from previous actions; however, such companies may present situations that could lead to possible breaches, without these being the responsibility of PROCOLOMBIA, which is why both exporters and buyers must ensure that they use secure negotiation tools, seek advice from experts to assess commercial risks and formalize the contractual documents that may be necessary to shield their conversations.
  4. ProColombia will in no case be responsible for the information of the companies and/or products available on this platform since it is filled out completely by each one of the companies.
Icon
Description

With a growing pharmaceutical company and manufacturing industry, a well established healthcare system, and sustainable investment on health research, Colombia continues to be an attractive place for investors and international companies to put their bet on the country.

What positions Colombia as one of the best pharma manufacturers in Latin America is its biodiversity, flexible trade agreements allowing the country to be a great exportation hub and access to innovative technology.

The country’s rich biodiversity offers great opportunity to develop natural products attracting more global companies.

The local production of generic drugs, over-the-counter pharmaceutical products and patent medicines has created a great potential to attract new global markets and multinational companies.

In 2015, pharmaceutical and chemical supplier companies in Colombia exported goods that were worth $525.4 million U.S dollars.
Pharmacy laboratories and pharmaceutical companies in Colombia are well equipped in terms of technology to meet the quality and production standards needed to deliver the best high end pharmacy supplies.

Bogota, the capital of Colombia, holds most of the country’s market with 66% of pharma manufacturers producing pharmaceutical products and where 65% are wholesalers distributors. The city is responsible for 47% of all exportation becoming an important hub to develop chemical synthesis medicines.

The main export destinations are Ecuador, Venezuela, Peru, Panama and the United States.

It is expected for the Colombian pharmaceutical market to grow at a rate of around 7.3 percent and reach a USD 7.1 billion valuation by 2020.
There is no doubt that Colombia offers a great deal for regional production and distribution hubs for pharmaceutical products.

 

Image
Farmacéuticos

Furthas darunavir * 800mg fco * 30 tablets and * 600MG FCO * 60 tablets

Furthas darunavir * 800mg fco * 30 tablets and * 600MG FCO * 60 tablets Image
Furthas darunavir * 800mg fco * 30 tablets and * 600MG FCO * 60 tablets Image
Treatment of human immunodeficiency virus (HIV) infection in adult patients with experience in antiretroviral therapy.

Duopetsa tenofovir emtricitabine 300 mg 200 mg * 30 tablets

Duopetsa tenofovir emtricitabine 300 mg 200 mg * 30 tablets Image
Duopetsa tenofovir emtricitabine 300 mg 200 mg * 30 tablets Image
Treatment of human immunodeficiency virus (HIV) infection in adult patients with experience in antiretroviral therapy.

The Labs S.A.S

At The Labs we have a solid strategy, to work for a country with a population that is growing and aging, with clear needs for timely access to quality medicines. Our strategy preserves the mission of The Labs, Adding value to our patients and to the Colombian health system. We are convinced that all the actors in the system must contribute to make it sustainable. For this reason, The Labs focuses on 2 key areas: * Access - Identifying the needs of EPS and IPS at the national level * Commercial - Structuring negotiation models, with reasonable prices, adjusted to reality.

Medical devices

Medical devices Image
Medical devices Image
Manufacturing, packaging and conditioning of medical devices:
-Pre-filled syringes

Common non-sterile molecules, non-beta-lactam antibiotics, non-steroidal corticosteroids

 Common non-sterile molecules, non-beta-lactam antibiotics, non-steroidal corticosteroids Image
 Common non-sterile molecules, non-beta-lactam antibiotics, non-steroidal corticosteroids Image
 Common non-sterile molecules, non-beta-lactam antibiotics, non-steroidal corticosteroids Image
 Common non-sterile molecules, non-beta-lactam antibiotics, non-steroidal corticosteroids Image
 Common non-sterile molecules, non-beta-lactam antibiotics, non-steroidal corticosteroids Image
Line of solids:
-Tablets and coating tablets.
-Hard capsules

Liquid Line:
-Syrups
-Suspensions and other liquid products

Semi-solid line
-Gels
-Creams

Laboratorios Demac Ltda

We provide our clients with an integral service that goes from the development and permanent innovation in the different branches of the cosmetic and pharmaceutical sector, to the specialized and personalized attention to directly attend their needs, according to the logistics that we jointly establish.

Design, development and manufacturing of cosmetic, pharmaceutical, medical devices and veterinary products, and brand extension.
Advice on packaging materials for your products.
Legal technical assistance for regulatory procedures before regulatory entities.
Logistic support at national and international level (we are exporters).
Multidisciplinary technical team to support your project.

AKATOENE - POLYDOCANOL 3% / 50ml

HS code
AKATOENE - POLYDOCANOL 3% / 50ml Image
AKATOENE - POLYDOCANOL 3% / 50ml Image
POLIDOCANOL IS AN ANESTHETIC THAT ACTS LOCALLY IN A REVERSIBLE MANNER, BOTH ON THE RECEPTORS AND ON THE CONDUCTION CAPACITY OF NERVE FIBERS, WHICH EXPLAINS THE ALMOST PAIN-FREE THERAPY.

POLIDOCANOL IS A VASCULAR SCLEROSING AGENT INDICATED TO TREAT ESOPHAGEAL VARICES, LOWER LIMB VARICES AND HEMORRHOIDS.

ZOCILED - TRANEXAMIC ACID 500mg/5ml

HS code
ZOCILED - TRANEXAMIC ACID 500mg/5ml Image
ZOCILED - TRANEXAMIC ACID 500mg/5ml Image
TRANEXAMIC ACID IS USED IN THE PREVENTION AND TREATMENT OF BLEEDING DUE TO GENERAL OR LOCAL FIBRINOLYSIS IN ADULTS AND CHILDREN OVER 1 YEAR OF AGE.
-ABNORMAL BLEEDING IN OPERATIONS (ESPECIALLY TO THE LUNGS, HEART, PROSTATE, KIDNEYS, UTERUS, TUMORS
-GENITAL BLEEDING (FUNCTIONAL UTERINE BLEEDING, BLEEDING AFTER ARTIFICIAL ABORTION, BLEEDING DUE TO MYOMA OF THE UTERUS, BLEEDING DUE TO PROSTATIC CANCER, PROSTATIC HYPERTROPHY, HEMORRHAGIC CYSTITIS).

HEMORRHAGIC DISEASES: PURPURA, APLASTIC ANEMIA, HEMOPHILIA, LEUKEMIA. HEMOPTISIS. NASAL AND GINGIVAL BLEEDING.

ADENOSINE 6mg/2ml

HS code
ADENOSINE 6mg/2ml Image
ADENOSINE 6mg/2ml Image
IT IS A CORONARY VASODILATOR THAT INCREASES BLOOD FLOW IN THE HEART MUSCLE. THIS DRUG IS USED FOR THE DIAGNOSIS AND TREATMENT OF SOME CARDIAC RHYTHM DISTURBANCES.

ADENOSINE IS FOR HOSPITAL USE ONLY AND MUST HAVE ELECTROPHYSIOLOGICAL MONITORING AND CARDIORESPIRATORY RESUSCITATION.

ETHYLEPHRINE HYDROCHLORIDE 10mg/ml

HS code
ETHYLEPHRINE HYDROCHLORIDE 10mg/ml Image
ETHYLEPHRINE HYDROCHLORIDE 10mg/ml Image
IT IS A VASOPRESSOR THAT ELEVATES BLOOD PRESSURE AND CARDIAC ACTIVITY, DUE TO ITS VASOCONSTRICTOR (DECREASE IN VESSEL CALIBER) AND CARDIAC STIMULANT EFFECT.

ETILEFRIN IS EXCLUSIVELY FOR HOSPITAL USE, SINCE IT MUST BE ADMINISTERED INTRAVENOUSLY IN AN INTENSIVE CARE UNIT WITH REGULAR MONITORING OF BLOOD PRESSURE AND CENTRAL VENOUS PRESSURE.